0.871
0.87 (0%)
As of Dec 24, 2024
Processa Pharmaceuticals, Inc. [PCSA]
Source:
Company Overview
Processa Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on utilizing the Processa Regulatory Science Approach, including the principles associated with FDA’s Project Optimus Oncology initiative and the related FDA Draft Guidance, in the development of Next Generation Chemotherapy oncology drug products.
Country | United States |
Headquarters | hanover, maryland |
Phone Number | 443-776-3133 |
Industry | manufacturing |
CEO | George Ng |
Website | www.processapharmaceuticals.com |